[{"address1": "Gooimeer 2-35", "city": "Naarden", "zip": "1411 DC", "country": "Netherlands", "phone": "31 35 206 2971", "website": "https://www.newamsterdampharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.", "fullTimeEmployees": 68, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael Harvey Davidson FACC, Facp., M.D.", "age": 68, "title": "CEO, President & Executive Board Member", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 1122237, "exercisedValue": 0, "unexercisedValue": 51427864}, {"maxAge": 1, "name": "Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D.", "age": 70, "title": "Founder, Chief Scientific Officer, Member of Executive Board & Director", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 813077, "exercisedValue": 4094829, "unexercisedValue": 35092304}, {"maxAge": 1, "name": "Mr. Mayur Amrat Somaiya", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 841238, "exercisedValue": 0, "unexercisedValue": 3954412}, {"maxAge": 1, "name": "Mr. Douglas F. Kling", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 913742, "exercisedValue": 0, "unexercisedValue": 17441960}, {"maxAge": 1, "name": "Ms. Juliette  Audet M.B.A., M.Sc.", "age": 37, "title": "Chief Strategy & Business Officer", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 653039, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Kooij", "age": 48, "title": "Chief Accounting Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Philippe", "title": "Executive VP &Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bob  Rambo", "title": "Executive Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maryellen  McQuade", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marc  Ditmarsch M.D.", "age": 57, "title": "Chief Development Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 36.42, "open": 35.84, "dayLow": 35.66, "dayHigh": 39.45, "regularMarketPreviousClose": 36.42, "regularMarketOpen": 35.84, "regularMarketDayLow": 35.66, "regularMarketDayHigh": 39.45, "payoutRatio": 0.0, "beta": 0.058, "forwardPE": -20.291004, "volume": 1569481, "regularMarketVolume": 1569481, "averageVolume": 1077453, "averageVolume10days": 1005100, "averageDailyVolume10Day": 1005100, "bid": 38.22, "ask": 38.48, "bidSize": 2, "askSize": 2, "marketCap": 4348536832, "fiftyTwoWeekLow": 14.06, "fiftyTwoWeekHigh": 41.47, "allTimeHigh": 41.47, "allTimeLow": 5.633, "priceToSalesTrailing12Months": 123.38725, "fiftyDayAverage": 32.5142, "twoHundredDayAverage": 23.59005, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3645857280, "profitMargins": 0.0, "floatShares": 57074127, "sharesOutstanding": 113390804, "sharesShort": 6424987, "sharesShortPriorMonth": 7640225, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.056700002, "heldPercentInsiders": 0.0038299998, "heldPercentInstitutions": 1.12664, "shortRatio": 5.01, "shortPercentOfFloat": 0.0675, "impliedSharesOutstanding": 113390804, "bookValue": 6.433, "priceToBook": 5.9614487, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -221072992, "trailingEps": -2.04, "forwardEps": -1.89, "enterpriseToRevenue": 103.449, "enterpriseToEbitda": -17.985, "52WeekChange": 0.47688568, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 38.35, "targetHighPrice": 60.37666, "targetLowPrice": 30.383633, "targetMeanPrice": 45.582253, "targetMedianPrice": 44.775635, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 13, "totalCash": 702945984, "totalCashPerShare": 6.199, "ebitda": -202720000, "totalDebt": 266000, "quickRatio": 12.411, "currentRatio": 12.567, "totalRevenue": 35243000, "debtToEquity": 0.037, "revenuePerShare": 0.311, "returnOnAssets": -0.20697, "returnOnEquity": -0.39943, "grossProfits": 35243000, "freeCashflow": -69113504, "operatingCashflow": -144388992, "revenueGrowth": -0.988, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -158.45691, "financialCurrency": "USD", "symbol": "NAMS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "NewAmsterdam Pharma Company N.V.", "marketState": "CLOSED", "shortName": "NewAmsterdam Pharma Company N.V", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612881000000, "postMarketChangePercent": 0.20835112, "postMarketPrice": 38.4299, "postMarketChange": 0.07990265, "regularMarketChange": 1.93, "regularMarketDayRange": "35.66 - 39.45", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1077453, "fiftyTwoWeekLowChange": 24.289997, "fiftyTwoWeekLowChangePercent": 1.7275958, "fiftyTwoWeekRange": "14.06 - 41.47", "fiftyTwoWeekHighChange": -3.1200027, "fiftyTwoWeekHighChangePercent": -0.07523517, "fiftyTwoWeekChangePercent": 47.68857, "earningsTimestamp": 1762349400, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "isEarningsDateEstimate": false, "corporateActions": [], "postMarketTime": 1763166925, "regularMarketTime": 1763154001, "exchange": "NGM", "messageBoardId": "finmb_685404834", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 5.29929, "regularMarketPrice": 38.35, "epsTrailingTwelveMonths": -2.04, "epsForward": -1.89, "epsCurrentYear": -1.35512, "priceEpsCurrentYear": -28.300077, "fiftyDayAverageChange": 5.8358, "fiftyDayAverageChangePercent": 0.17948467, "twoHundredDayAverageChange": 14.759949, "twoHundredDayAverageChangePercent": 0.62568533, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-11-23", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "NewAmsterdam Pharma Company", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]